JPWO2021079869A1 - - Google Patents

Info

Publication number
JPWO2021079869A1
JPWO2021079869A1 JP2021553451A JP2021553451A JPWO2021079869A1 JP WO2021079869 A1 JPWO2021079869 A1 JP WO2021079869A1 JP 2021553451 A JP2021553451 A JP 2021553451A JP 2021553451 A JP2021553451 A JP 2021553451A JP WO2021079869 A1 JPWO2021079869 A1 JP WO2021079869A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021553451A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2021079869A1 publication Critical patent/JPWO2021079869A1/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2021553451A 2019-10-21 2020-10-20 Pending JPWO2021079869A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019191754 2019-10-21
PCT/JP2020/039359 WO2021079869A1 (ja) 2019-10-21 2020-10-20 尿毒素軽減剤

Publications (1)

Publication Number Publication Date
JPWO2021079869A1 true JPWO2021079869A1 (cg-RX-API-DMAC7.html) 2021-04-29

Family

ID=75620690

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021553451A Pending JPWO2021079869A1 (cg-RX-API-DMAC7.html) 2019-10-21 2020-10-20

Country Status (8)

Country Link
US (1) US20220387526A1 (cg-RX-API-DMAC7.html)
EP (1) EP4049667A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2021079869A1 (cg-RX-API-DMAC7.html)
CN (2) CN118252856A (cg-RX-API-DMAC7.html)
MX (1) MX2022004635A (cg-RX-API-DMAC7.html)
PH (1) PH12022550966A1 (cg-RX-API-DMAC7.html)
TW (1) TWI870485B (cg-RX-API-DMAC7.html)
WO (1) WO2021079869A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116585360A (zh) * 2023-05-24 2023-08-15 微康益生菌(苏州)股份有限公司 一种改善慢性肾病的益生菌剂及其应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102362828B1 (ko) * 2021-06-17 2022-02-15 주식회사 비피도 비피도박테리움 비피덤 bgn4를 함유한 신부전 개선용, 치료용 또는 예방용 조성물
JP7504490B2 (ja) * 2022-09-01 2024-06-24 合同会社AiMIYA 重度腎不全に罹患するネコ科動物における尿毒症の悪化を抑制するための剤
CN115887483B (zh) * 2022-09-29 2025-12-16 百施(上海)生物科技有限公司 发酵乳杆菌cect 5716胞外多糖在制备预防或改善慢性肾脏疾病中的应用
CN115887502A (zh) * 2022-11-29 2023-04-04 中国人民解放军空军军医大学 粪副拟杆菌在制备防治心力衰竭药物中的应用
CN120330113B (zh) * 2025-06-23 2025-09-16 上海菌济健康科技有限公司 具有尿酸降解及护肾作用的乳酸片球菌pa3-7及其应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271223A (ja) * 1985-05-24 1986-12-01 Biofuerumin Seiyaku Kk 血中脂質改善剤
JPH09110707A (ja) * 1995-10-12 1997-04-28 Wakamoto Pharmaceut Co Ltd 慢性腎不全改善剤および透析患者のクオリティー オブ ライフ改善剤
JP2003252772A (ja) * 2002-03-04 2003-09-10 Snow Brand Milk Prod Co Ltd 加齢に伴う代謝異常症の予防・改善・治療剤
JP2004277296A (ja) * 2003-03-13 2004-10-07 Morishita Jintan Kk 乳酸菌含有腸溶性製剤
WO2011114916A1 (ja) * 2010-03-18 2011-09-22 森永乳業株式会社 貧血の予防又は治療用組成物
WO2012005240A1 (ja) * 2010-07-05 2012-01-12 株式会社明治 腸内腐敗物質の低減作用を有するビフィズス菌
WO2018003899A1 (ja) * 2016-06-30 2018-01-04 アサヒグループホールディングス株式会社 腎性貧血改善用組成物
WO2018074514A1 (ja) * 2016-10-20 2018-04-26 ビオフェルミン製薬株式会社 腸管のイオン経細胞輸送体への作用剤、クロライドチャネル活性化剤、腎疾患の予防もしくは治療剤、又は排便促進剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050239706A1 (en) * 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
EP2221360B1 (en) * 2007-11-30 2014-03-05 Meiji Co., Ltd. Lactic acid bacterium having effect of lowering blood uric acid level
ES2436251B1 (es) * 2012-05-25 2014-10-08 Consejo Superior De Investigaciones Científicas (Csic) Bacteroides cect 7771 y su uso en la prevención y tratamiento de sobrepeso, obesidad y alteraciones metabólicas e inmunológicas.
WO2014036182A2 (en) 2012-08-29 2014-03-06 California Institute Of Technology Diagnosis and treatment of autism spectrum disorder
TWI481409B (zh) 2013-01-10 2015-04-21 Conmed Pharmaceutical & Bio Medical Corp 一種使用益生菌製備用於清除尿毒素之組合物的用途
PT3071235T (pt) * 2015-01-26 2018-02-21 Kaleido Biosciences Inc Produtos terapêuticos de glicanos e respetivos métodos relacionados
WO2019087842A1 (ja) * 2017-11-01 2019-05-09 ビオフェルミン製薬株式会社 非ステロイド性抗炎症薬及びプロトンポンプ阻害薬誘発性小腸障害の予防又は治療剤

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271223A (ja) * 1985-05-24 1986-12-01 Biofuerumin Seiyaku Kk 血中脂質改善剤
JPH0656681A (ja) * 1985-05-24 1994-03-01 Biofuerumin Seiyaku Kk 血中トリグリセライド値改善剤
JPH09110707A (ja) * 1995-10-12 1997-04-28 Wakamoto Pharmaceut Co Ltd 慢性腎不全改善剤および透析患者のクオリティー オブ ライフ改善剤
JP2003252772A (ja) * 2002-03-04 2003-09-10 Snow Brand Milk Prod Co Ltd 加齢に伴う代謝異常症の予防・改善・治療剤
JP2004277296A (ja) * 2003-03-13 2004-10-07 Morishita Jintan Kk 乳酸菌含有腸溶性製剤
WO2011114916A1 (ja) * 2010-03-18 2011-09-22 森永乳業株式会社 貧血の予防又は治療用組成物
WO2012005240A1 (ja) * 2010-07-05 2012-01-12 株式会社明治 腸内腐敗物質の低減作用を有するビフィズス菌
WO2018003899A1 (ja) * 2016-06-30 2018-01-04 アサヒグループホールディングス株式会社 腎性貧血改善用組成物
WO2018074514A1 (ja) * 2016-10-20 2018-04-26 ビオフェルミン製薬株式会社 腸管のイオン経細胞輸送体への作用剤、クロライドチャネル活性化剤、腎疾患の予防もしくは治療剤、又は排便促進剤

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
AL-SHERAJI, S.H. ET AL.: "Hypocholesterolaemic effect of yoghurt containing Bifidobacterium pseudocatenulatum G4 or Bifidobact", FOOD CHEMISTRY, vol. 135, no. 2, JPN6020045941, 2012, pages 356 - 361, ISSN: 0005432216 *
HOSONO, A. ET AL.: "Impact of fermented milk on human health: Cholesterol‐lowering and immunomodulatory properties of f", ANIMAL SCIENCE JOURNAL, vol. 73, JPN6020045938, 2002, pages 241 - 256, ISSN: 0005432215 *
IWASHITA, Y. ET AL.: "Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease P", AMERICAN JOURNAL OF NEPHROLOGY, vol. 47, no. 5, JPN6020045931, 2018, pages 325 - 332, ISSN: 0005432214 *
KONDO, S. ET AL.: "Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with high-f", BIOSCIENCE, BIOTECHNOLOGY, AND BIOCHEMISTRY, vol. 74, no. 8, JPN6020045944, 2010, pages 1656 - 1661, ISSN: 0005432217 *
TAKI, K. ET AL.: "Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia i", JOURNAL OF RENAL NUTRITION, vol. 15, no. 1, JPN6020045922, 2005, pages 77 - 80, ISSN: 0005432212 *
TOHYAMA, K. ET AL.: "Effect of lactobacilli on urinary indican excretion in gnotobiotic rats and in man", MICROBIOLOGY AND IMMUNOLOGY, vol. 25, no. 2, JPN6020045927, 1981, pages 101 - 112, ISSN: 0005432213 *
斉藤 喬雄: "腎障害における高脂血症と心血管系障害", 分子心血管病, vol. 第8巻, 第5号, JPN6020045946, 2007, pages 475 - 479, ISSN: 0005432218 *
石橋 俊: "知っておきたい脂質異常症のさまざまな病態", 薬事, vol. 第59巻, 第16号, JPN6020045948, 2017, pages 3259 - 3265, ISSN: 0005432219 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116585360A (zh) * 2023-05-24 2023-08-15 微康益生菌(苏州)股份有限公司 一种改善慢性肾病的益生菌剂及其应用
CN116585360B (zh) * 2023-05-24 2023-11-14 微康益生菌(苏州)股份有限公司 一种改善慢性肾病的益生菌剂及其应用

Also Published As

Publication number Publication date
WO2021079869A1 (ja) 2021-04-29
PH12022550966A1 (en) 2023-09-25
US20220387526A1 (en) 2022-12-08
MX2022004635A (es) 2022-05-10
CN114585375A (zh) 2022-06-03
EP4049667A1 (en) 2022-08-31
CN118252856A (zh) 2024-06-28
EP4049667A4 (en) 2024-02-21
TWI870485B (zh) 2025-01-21
TW202123949A (zh) 2021-07-01

Similar Documents

Publication Publication Date Title
BR112019017762A2 (cg-RX-API-DMAC7.html)
BR112021017339A2 (cg-RX-API-DMAC7.html)
BR112021018450A2 (cg-RX-API-DMAC7.html)
BR112021017637A2 (cg-RX-API-DMAC7.html)
BR112021017892A2 (cg-RX-API-DMAC7.html)
BR112021017782A2 (cg-RX-API-DMAC7.html)
BR112021016821A2 (cg-RX-API-DMAC7.html)
BR112021017939A2 (cg-RX-API-DMAC7.html)
BR112021017738A2 (cg-RX-API-DMAC7.html)
BR112021016996A2 (cg-RX-API-DMAC7.html)
JPWO2021079869A1 (cg-RX-API-DMAC7.html)
BR112021017728A2 (cg-RX-API-DMAC7.html)
BR112021013944A2 (cg-RX-API-DMAC7.html)
BR112021018452A2 (cg-RX-API-DMAC7.html)
BR112021017703A2 (cg-RX-API-DMAC7.html)
BR112021018102A2 (cg-RX-API-DMAC7.html)
BR112021017732A2 (cg-RX-API-DMAC7.html)
BR112021017234A2 (cg-RX-API-DMAC7.html)
BR112021017355A2 (cg-RX-API-DMAC7.html)
BR112021018168A2 (cg-RX-API-DMAC7.html)
BR112021018093A2 (cg-RX-API-DMAC7.html)
BR112021017173A2 (cg-RX-API-DMAC7.html)
BR112021017083A2 (cg-RX-API-DMAC7.html)
BR112021015080A2 (cg-RX-API-DMAC7.html)
BR112021018250A2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220218

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220307

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240702

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240827

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241008

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241204

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20241227

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250422